We have collected information about Pulmonary Drug Delivery Part I for you. Follow the links to find out details on Pulmonary Drug Delivery Part I.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884307/
Apr 19, 2002 · Pulmonary drug delivery offers several advantages as a route of administration for the treatment of systemic diseases compared with intravenous, oral, buccal, transdermal, vaginal, nasal or ocular administration. The advantages of pulmonary administration are listed in Table 1 [20–23]. Until recently, aerosol drug delivery has been limited to topical therapy for the lung and nose.Author: N. R. Labiris, M. B. Dolovich
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2125.2003.01892.x
Aug 20, 2003 · Pulmonary drug delivery offers several advantages as a route of administration for the treatment of systemic diseases compared with intravenous, oral, buccal, transdermal, vaginal, nasal or ocular administration. The advantages of pulmonary administration are listed in Table 1 [20-23].
https://www.ncbi.nlm.nih.gov/pubmed/14616418
As the end organ for the treatment of local diseases or as the route of administration for systemic therapies, the lung is a very attractive target for drug delivery. It provides direct access to disease in the treatment of respiratory diseases, while providing an enormous surface area and a relatively low enzymatic, controlled environment for systemic absorption of medications.Author: N. R. Labiris, M. B. Dolovich
https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2125.2003.01892.x
Aug 20, 2003 · As the end organ for the treatment of local diseases or as the route of administration for systemic therapies, the lung is a very attractive target for drug delivery. It provides direct access to disease in the treatment of respiratory diseases, while providing an enormous surface area and a relatively low enzymatic, controlled environment for systemic absorption of medications.Author: N. R. Labiris, M. B. Dolovich
https://www.researchgate.net/publication/9010801_Pulmonary_drug_delivery_Part_I_Physiological_factors_affecting_therapeutic_effectiveness_of_aerosolized_medications
Pulmonary drug delivery offers several advantages over injectable, transdermal or oral methods of delivery. ... These types of particles are desirable for inhalation due to the good flowability ...
https://www.pharmatutor.org/articles/pulmonary-drug-delivery-a-review
ADVANTAGES OF PULMONARY DRUG DELIVERY. 1. Inhaled drug delivery puts drug where it is needed. 2. It requires low and fraction of oral dose i.e. drug content of one 4 mg tablet of salbutamol equals to 40 doses of meter doses. 3.
https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/pulmonary-drug-delivery
Pulmonary drug delivery has many advantages compared to unusual drug delivery strategies, especially rapid drug uptake, a large surface area for solute transport, and improved drug bioavailability, as well as its noninvasive nature. 73–76 Antimicrobial agents enter into the lung by means of systemic nanoparticles administration, which is determined and potentially harmful upon systemic exposure to the drugs…
https://clinicalgate.com/pulmonary-drug-delivery/
• Pulmonary delivery may be used for drugs having local or systemic activity. • Effective drug delivery to the lungs is dependent on the formulation, the delivery device and the patient. • The structure of the airways is effective in preventing entry of materials, including therapeutic aerosols.
https://www.slideshare.net/MOHDIMRAN139/pulmonary-drug-delivery-system-87395339
Feb 07, 2018 · INTRODUCTION • Pulmonary drug delivery is primarily used to treat conditions of the airways, delivering locally acting drugs directly to their site of action. • Delivery of anti-asthmatic and other locally acting drugs directly to their site of action reduces the dose needed to produce a pharmacological effect,...
https://pdfs.semanticscholar.org/e11a/3bbc81c857aa476bda83691222dea8b862aa.pdf
APPROACHES IN PULMONARY DRUG DELIVERY Targeted drug delivery to the lungs has evolved to be one of the most widely investigated systemic or local drug delivery approaches. The use of drug delivery systems (DDS) for the treatment of pulmonary diseases is increasing because of their potential for localized topical therapy in the lungs.
Searching for Pulmonary Drug Delivery Part I?
You can just click the links above. The data is collected for you.
